Eisai Europe Ltd
Acronym: EEL
General Information
Identification Code: 486226117071-45
Website: http://www.eisai.eu
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 4/22/2015
Last Update: 2/8/2024
Mission & Interests
Goals: Around the world there are still many diseases for which no effective treatments exist and many patients who do not have adequate access to the medicines they need. As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Competition
- Consumers
- Customs
- Humanitarian aid and civil protection
- Public health
- Research and innovation
- Single market
- Taxation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Healthcare Policy
Pharmaceutical Legislation
Pharmaceutical Industrial Policy
Competition
Intellectual Property
Communication Activities: None
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: EMEA Knowledge CentreMosquito Way
Post Code: AL10 9SN
City: Hatfield
Country: UNITED KINGDOM
Phone:
Indic Phone: 44
Phone Number: 845 676 1400
EU Office
Address: EMEA Knowledge CentreMosquito Way
Post Code: AL10 9SN
City: Hatfield
Country: UNITED KINGDOM
Phone:
Indic Phone: 44
Phone Number: 845 676 1400
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Complementary Information: None
Membership Information
Members25 Percent: 2
Members: 2
Members F T E: 0.5
Info Members: 1 Senior Vice President Global Regulatory & Public Affairs EMEA
1 Chairman & CEO EMEA
Structure
Structure Type: Structure
Is Member Of: None
Organisation Members: European Federation of Pharmaceutical Industries and Associations
Current Job Opportunities
mid-levelBrussels, Francefull-time
Posted: 8/21/2025